my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
INTEGRA Biosciences AG has announced that they have signed an agreement to acquire their long time French distribution partner Valdea Biosciences SAS. The move will maintain all Valdea Biosciences' existing distribution partnerships and provides the resource to help accelerate the launch o ... more
Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a novel mechanism regulating the development of breast cancer bone metas ... more
A tiny filter could have a big impact around the world in the fight against tuberculosis. Using the traditional microscope-based diagnosis method as a starting point, a University of Florida lung disease specialist and colleagues in Brazil have devised a way to detect more cases of the bact ... more
Drugs under development to treat those affected by acute spinal cord injuries are not expected to emerge within the current decade, leaving the market largely open to new entrants, according to a new report issued by pharmaceuticals intelligence provider GlobalData.The new report, "Acute Sp ... more
Avalanche Biotechnologies, Inc. and Lonza announced a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene therapy. AAV vectors are rapidly becoming one of the most promising gene delivery vehi ... more
A team of Israeli and German scientists from Ben-Gurion University of the Negev and the Max Plank Institute of Colloids and Interfaces, Potsdam, have found an enamel-like layer in the mandibles of freshwater crayfish. The newly discovered structure bears an astonishing resemblance to human ... more
The 2012 Eppendorf Award is the 17th research prize conferred by the Hamburg life science company. This year it was presented to Elizabeth Murchison, Ph.D. (Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom). The official Award ceremony took place at the EMBL Advanced Trai ... more
Clearbridge BioMedics has won the 2012 Asian Entrepreneurship Awards, which was held from 9-11 May 2012 in Kashiwanoha, Chiba Prefecture in Japan. A total of 18 start-up companies, from 12 Asian countries presented their business plans at this inaugural business competition. Clearbridge B ... more
CryoLife, Inc. announced that it has signed a definitive agreement to acquire Hemosphere, Inc., a privately-held medical device company that has developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft. The HeRO Graft is a proprietary graft-based solution for end-stage renal dis ... more
Sygnature Discovery Limited and Pneumolabs (UK) Limited announced they have entered into a strategic alliance. Under the terms of the agreement, Sygnature and Pneumolabs will collaborate to provide a fully-integrated drug discovery service to accelerate clients’ drug discovery programmes i ... more
Lab21 Limited has secured new patents in Europe and the USA relating to Hepatitis C (HCV) drug resistance as it continues to expand its intellectual property portfolio in infectious disease testing. The patents cover technology allowing the genotypic identification of drug resistant mutat ... more
Beckman Coulter, Inc. has obtained a CLIA Certificate of Registration, along with Massachusetts State Licensure, allowing Beckman Coulter Genomics to begin accepting clinical samples for genetic sequencing – the most technically complex CLIA category – and to provide those results to physic ... more
Affymetrix, Inc., and eBioscience, Inc. announced they have amended their existing definitive agreement dated November 29, 2011 under which Affymetrix will acquire eBioscience. Under the terms of the amended agreement, Affymetrix will acquire eBioscience for $315 million in cash subject to ... more
Gaining access to the inner workings of a neuron in the living brain offers a wealth of useful information: its patterns of electrical activity, its shape, even a profile of which genes are turned on at a given moment. However, achieving this entry is such a painstaking task that it is cons ... more
Population Genetics Technologies Ltd. has appointed Alan Schafer, PhD to the post of Chief Executive Officer. Schafer brings deep experience in research, “big pharma” management and building new businesses. He is Adjunct Professor of Innovation at Imperial College London Business School and ... more
Trinean NV announced the appointment of Philippe Stas as it’s new CEO, succeeding Dr. Marc Zabeau, who remains a member of the board of directors. Simultaneously, Trinean announced that the company has secured 2.7 million euro of growth financing provided by its existing investors. Prior to ... more
A University of Granada researcher has been awarded the Best Film of the Year at the SkyScan Micro CT Meeting, an international conference of computed microtomography recently celebrated in Brussels, Belgium. Professor Javier Alba Tercedor, of the Department of Zoology has been awarded for ... more
SeraCare Life Sciences announced that Charlie Mamrak joined the company as CEO and Harold (Bud) Ingalls has joined as CFO. Both executives bring extensive experience in the biosciences industry and a vision for SeraCare to drive the growth of precision medicine by enabling customized testin ... more
The latest advance in solid-state nanopore sensors – devices that are made with standard tools of the semiconductor industry yet can offer single-molecule sensitivity for label-free protein screening – expands their bag of tricks through bionanotechnology. Researchers at the Technische Univ ... more
A study by The Genographic Project has found that the majority of all known ethnic Afghans share a unique genetic heritage derived from a common ancestral population that most likely emerged during the Neolithic revolution and the formation of early farming communities. Through detailed DNA ... more
INTEGRA Biosciences AG has announced that they have signed an agreement to acquire their long time French distribution partner Valdea Biosciences SAS. The move will maintain all Valdea Biosciences' existing distribution partnerships and provides the resource to help accelerate the launch o ... more
Avalanche Biotechnologies, Inc. and Lonza announced a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene therapy. AAV vectors are rapidly becoming one of the most promising gene delivery vehi ... more
Clearbridge BioMedics has won the 2012 Asian Entrepreneurship Awards, which was held from 9-11 May 2012 in Kashiwanoha, Chiba Prefecture in Japan. A total of 18 start-up companies, from 12 Asian countries presented their business plans at this inaugural business competition. Clearbridge B ... more
Gene therapy allows older mice to live longer, healthier lives report researchers in a new study published in EMBO Molecular Medicine. Mice that received a single gene-therapy treatment to deliver telomerase to different cells in the body showed drastic improvements in health, fitness and l ... more
Promethera Biosciences, a Belgian biotechnology company developing Promethera (R) HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announced it has treated its first two patients with its treatment ... more
Scientists at A*STAR's Institute of Medical Biology (IMB), in collaboration with doctors and scientists in Jordan, Turkey, Switzerland and USA, have identified the genetic cause of a birth defect known as Hamamy syndrome. Their groundbreaking findings were published in Nature Genetics. The ... more
The research team of Professor Johanna Ivaska (University of Turku and VTT Technical Research Centre of Finland) screened dozens of prostate cancers using gene silencing and discovered mechanisms of that inhibit the spread of cancer cells.Published in the Journal of Cell Science, the study ... more
The foundation of biological inheritance is DNA replication – a tightly coordinated process in which DNA is simultaneously copied at hundreds of thousands of different sites across the genome. If that copying mechanism doesn't work as it should, the result could be cells with missing or ext ... more
A team of students from the University of Manchester, UK, has been awarded an international sustainability prize by the Institution of Chemical Engineers (IChemE) in recognition of a university design project based on turning corn waste into succinic acid.The seven-strong team that clinch ... more
Kentucky Bioprocessing, LLC (KBP), Icon Genetics, GmbH (ICON) and Mapp Biopharmaceutical, Inc. (Mappbio) have announced that they have entered into detailed negotiations aimed at merging the companies to create a single, fully integrated biopharmaceutical discovery, development and manufac ... more
A tiny filter could have a big impact around the world in the fight against tuberculosis. Using the traditional microscope-based diagnosis method as a starting point, a University of Florida lung disease specialist and colleagues in Brazil have devised a way to detect more cases of the bact ... more
Lab21 Limited has secured new patents in Europe and the USA relating to Hepatitis C (HCV) drug resistance as it continues to expand its intellectual property portfolio in infectious disease testing. The patents cover technology allowing the genotypic identification of drug resistant mutat ... more
Agenix Limited announced that Japan's Patent Office had granted a key patent covering the manufacturing process of its ThromboView® imaging agent for the detection of blood clots in humans. Agenix Chairman and Chief Executive Officer, Nicholas Weston said, "The granting of patent protectio ... more
Eye color may be an indicator of whether a person is high-risk for certain serious skin conditions. A study, led by the University of Colorado School of Medicine, shows people with blue eyes are less likely to have vitiligo. It then follows, according to scientists, that people with brown e ... more
QIAGEN N.V. announced the acquisition of AmniSure International LLC, a privately owned Boston company that markets the AmniSure® assay for determining whether a pregnant woman is suffering rupture of fetal membranes (ROM), a condition in which fluid leaks from the amniotic sac prematurely. ... more
LifeCodexx AG announced the successful completion of the clinical validation study of its noninvasive test method for the detection of fetal trisomy 21 from maternal blood using Next Generation sequencing. First results from the prospective blinded multi-center study demonstrate highest cli ... more
SeraCare Life Sciences announced that Charlie Mamrak joined the company as CEO and Harold (Bud) Ingalls has joined as CFO. Both executives bring extensive experience in the biosciences industry and a vision for SeraCare to drive the growth of precision medicine by enabling customized testin ... more
Studying a mouse model of Alzheimer's disease, neuroscientists at the Technische Universitaet Muenchen have observed correlations between increases in both soluble and plaque-forming beta-amyloid – a protein implicated in the disease process – and dysfunctional developments on several level ... more
Chemical alterations of the genetic information specifically occuring during carcinogenesis provide the basis for the innovative diagnostic tests that are developed by the newly established oncgnostics GmbH in Jena. These tests allow not only for an earlier, but also a more accurate detecti ... more
Piramal Healthcare Limited announced that it has signed an agreement to acquire worldwide rights to the molecular imaging research and development portfolio of Bayer Pharma AG through its newly created subsidiary - Piramal Imaging SA. The portfolio includes rights to florbetaben, which is ... more
INTEGRA Biosciences AG has announced that they have signed an agreement to acquire their long time French distribution partner Valdea Biosciences SAS. The move will maintain all Valdea Biosciences' existing distribution partnerships and provides the resource to help accelerate the launch o ... more
VWR International, LLC announced that it has signed an agreement to acquire basan Germany GmbH, including its subsidiaries and operations in The Netherlands, France, Italy, Singapore, Malaysia and Vietnam. The agreement is subject to customary closing conditions and regulatory approval in G ... more
Sartorius started off fiscal 2012 with substantial gains in order intake, sales revenue and earnings. Based on the company's excellent quarterly performance, management confirmed its full-year guidance: “In all divisions and regions, we are well on track. It is also encouraging that we have ... more
The 23rd analytica, the International Trade Fair for Laboratory Technology, Analysis and Biotechnology, concluded in Munich with more than 30,000 visitors. The three new Live Labs on the topics of Forensics and Clinical Diagnostics, Plastics Analysis and Food and Water Analysis were popular ... more
Fluidigm Corporation has begun direct service to customers in China. Through the establishment of a wholly-owned Fluidigm subsidiary in China in late January 2012, officially known as Fluidigm (Shanghai) Instrument Technology Co., Ltd., Fluidigm will improve services to its Chinese customer ... more
The 23rd analytica, the International Trade Fair for Laboratory Technology, Analysis and Biotechnology, has opened its gates in Munich with 1,026 exhibitors from 37 countries. This year’s fair revolves around new Live Labs, three completely equipped laboratories. In addition, the scientific ... more
Effective immediately, smartphone users and owners of mobile terminal devices can download the analytica App at analytica-app.de. With just a few clicks, interested users can access all important information that pertains to the fair – from an interactive hall diagram and program highlights ... more
Corning Incorporated announced that it has reached a definitive agreement with BD(Becton, Dickinson and Company) (NYSE:BDX) to acquire the majority of its Discovery Labware unit for approximately $730 million in cash. The acquisition is expected to be completed later this year, subject to c ... more
Some 1,000 exhibitors from the laboratory-technology, analysis and biotechnology sectors will present their latest products at analytica in Munich from April 17 – 20. Besides the exhibition and the scientific analytica Conference, a practice-oriented program of related events awaits visitor ... more
Sartorius closed the year 2011 with double-digit sales growth and boosted its earnings by nearly a third. At the annual press conference for the company in Goettingen, Germany, Group CEO Dr. Joachim Kreuzburg indicated that 2011 was an especially forward-looking year beyond the company’s fi ... more
Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a novel mechanism regulating the development of breast cancer bone metas ... more
Drugs under development to treat those affected by acute spinal cord injuries are not expected to emerge within the current decade, leaving the market largely open to new entrants, according to a new report issued by pharmaceuticals intelligence provider GlobalData.The new report, "Acute Sp ... more
Avalanche Biotechnologies, Inc. and Lonza announced a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene therapy. AAV vectors are rapidly becoming one of the most promising gene delivery vehi ... more
Clearbridge BioMedics has won the 2012 Asian Entrepreneurship Awards, which was held from 9-11 May 2012 in Kashiwanoha, Chiba Prefecture in Japan. A total of 18 start-up companies, from 12 Asian countries presented their business plans at this inaugural business competition. Clearbridge B ... more
Sygnature Discovery Limited and Pneumolabs (UK) Limited announced they have entered into a strategic alliance. Under the terms of the agreement, Sygnature and Pneumolabs will collaborate to provide a fully-integrated drug discovery service to accelerate clients’ drug discovery programmes i ... more
Medivir AB announced that it has appointed Henric Juserius to be the new head of the company's commercial activities. Henric, who will have overall responsibility for Medivir’s pharmaceutical marketing and sales, will join the company in August 2012 and will be part of the management team.H ... more
“Merck delivered a reasonable operating performance in the face of a difficult year-over-year comparison,” said Karl-Ludwig Kley, Chairman of the Executive Board of Merck. “During the first quarter, we kicked off our efficiency program and announced the first planned initiatives as part of ... more
BioGaia has initiated an investigative study in type 2 diabetics together with Gothia Forum for Clinical Research at Sahlgrenska University Hospital in Gothenburg in collaboration with Sahlgrenska Center for Cardiovascular and Metabolic Research. Based on encouraging findings after suppleme ... more
Intercell AG announced that it successfully completed a previously announced financing transaction consisting of a EUR 20.0 million secured loan (the “Term Loan”) provided by BB Biotech and an equity private placement (the “Private Placement”) of approximately EUR 15.2 million. The Intercel ... more
Amakem NV announced the appointment of Dr. Steve Pakola as Chief Medical Officer and Dr. George Lasezkay to its Board as an Independent Director. Both have exceptional track records in the biotechnology industry and bring a wealth of ophthalmology experience to Amakem.Dr. Pakola was previou ... more
Drugs under development to treat those affected by acute spinal cord injuries are not expected to emerge within the current decade, leaving the market largely open to new entrants, according to a new report issued by pharmaceuticals intelligence provider GlobalData.The new report, "Acute Sp ... more
The 2012 Eppendorf Award is the 17th research prize conferred by the Hamburg life science company. This year it was presented to Elizabeth Murchison, Ph.D. (Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom). The official Award ceremony took place at the EMBL Advanced Trai ... more
CryoLife, Inc. announced that it has signed a definitive agreement to acquire Hemosphere, Inc., a privately-held medical device company that has developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft. The HeRO Graft is a proprietary graft-based solution for end-stage renal dis ... more
Gene therapy allows older mice to live longer, healthier lives report researchers in a new study published in EMBO Molecular Medicine. Mice that received a single gene-therapy treatment to deliver telomerase to different cells in the body showed drastic improvements in health, fitness and l ... more
Promethera Biosciences, a Belgian biotechnology company developing Promethera (R) HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announced it has treated its first two patients with its treatment ... more
Scientists at A*STAR's Institute of Medical Biology (IMB), in collaboration with doctors and scientists in Jordan, Turkey, Switzerland and USA, have identified the genetic cause of a birth defect known as Hamamy syndrome. Their groundbreaking findings were published in Nature Genetics. The ... more
Chemicals which disrupt the hormone system – also known as ‘endocrine disrupting chemicals’ (EDCs) – may be behind significant increases in cancers, diabetes and obesity, falling fertility, and an increased number of neurological development problems in both humans and animals, according t ... more
The research team of Professor Johanna Ivaska (University of Turku and VTT Technical Research Centre of Finland) screened dozens of prostate cancers using gene silencing and discovered mechanisms of that inhibit the spread of cancer cells.Published in the Journal of Cell Science, the study ... more
BRAIN AG announced the granting of a European patent in the field of biotechnological wound conditioning. This new substance patent, registered under the official number EP2245150 B1, was invented by BRAIN within the scope of a BMBF supported research program (FKZ: 0313916). The patent desc ... more
From tiny villages in developing nations to suburban kitchens in the United States, dangerous strains of E. coli bacteria sicken millions of people each year – and kill untold numbers of children. Now, new research from the University of Michigan Health System gives scientists a better unde ... more
Dr. Dirk Ehle appointed Head of Bayer HealthCare's Animal Health Division
Single-neuron observations mark steps in Alzheimer's disease
BGU Kahn Center research group unravels genetic mutations for intestinal obs ...
Direct transfer of plant genes from chloroplasts into the cell nucleus
Final report analytica 2012: Decision-makers announce definite intentions to ...
A study by IRB Barcelona sheds light on the reasons behind genomes differenc ...
Genetic regulators hijacked by avian and swine flu viruses identified: UBC study
Novel compound halts tumor spread, improves brain cancer treatment in animal ...
A double ring ceremony prepares telomerase RNA to wed its protein partner
Bioelectronics: Invention of the pH imaging microscope for applications incl ...
BioGaia has initiated an investigative study in type 2 diabetics together with Gothia Forum for Clinical Research at Sahlgrenska University Hospital in Gothenburg in collaboration with Sahlgrenska Center for Cardiovascular and Metabolic Research. Based on encouraging findings after suppleme ... more
Promethera Biosciences, a Belgian biotechnology company developing Promethera (R) HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announced it has treated its first two patients with its treatment ... more
Mucosis B.V. announced Phase I clinical data providing proof-of-concept that Mimopath®-based mucosal vaccines are safe and well tolerated as well as able to produce balanced immune responses in both circulating blood and the respiratory tract.Mucosis, in conjunction with the Centre for Huma ... more
INTEGRA Biosciences AG has announced that they have signed an agreement to acquire their long time French distribution partner Valdea Biosciences SAS. The move will maintain all Valdea Biosciences' existing distribution partnerships and provides the resource to help accelerate the launch o ... more
CryoLife, Inc. announced that it has signed a definitive agreement to acquire Hemosphere, Inc., a privately-held medical device company that has developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft. The HeRO Graft is a proprietary graft-based solution for end-stage renal dis ... more
Copley Scientific is expanding its world-wide distribution network with the appointment of new partners in Turkey, Brazil and China.“Copley Scientific aims to provide the very highest levels of localised service to all its customers, around the world,” said Sales Director Mark Copley, “s ... more
Effective immediately, Evonik Industries is increasing the prices for the products L-Ornithine-L-Aspartate, L-Proline, L-Lysine salts, L-Methionine, L-Arginine-L-Aspartate, Glycine and all other cGMP-grade amino acids. The increase amounts to 10 – 20 percents and applies globally to all new ... more
Effective September 1, 2011, BASF will increase the sales prices globally for all pharmaceutical excipients and generic active pharmaceutical ingredients by 10%. This price increase affects the entire excipients portfolio including all binders, disintegrants, coatings, solubilizers, and sol ... more
Medivir AB announced results from the ASPIRE phase 2b study that evaluates the addition of once daily TMC435 to pegylated interferon and ribavirin in patients with genotype 1 chronic hepatitis C whose prior treatment with pegylated-interferon (PegIFN) and ribavirin (RBV) was unsuccessful ei ... more
Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a novel mechanism regulating the development of breast cancer bone metas ... more
A tiny filter could have a big impact around the world in the fight against tuberculosis. Using the traditional microscope-based diagnosis method as a starting point, a University of Florida lung disease specialist and colleagues in Brazil have devised a way to detect more cases of the bact ... more
A team of Israeli and German scientists from Ben-Gurion University of the Negev and the Max Plank Institute of Colloids and Interfaces, Potsdam, have found an enamel-like layer in the mandibles of freshwater crayfish. The newly discovered structure bears an astonishing resemblance to human ... more
Medivir AB announced that it has appointed Henric Juserius to be the new head of the company's commercial activities. Henric, who will have overall responsibility for Medivir’s pharmaceutical marketing and sales, will join the company in August 2012 and will be part of the management team.H ... more
Amakem NV announced the appointment of Dr. Steve Pakola as Chief Medical Officer and Dr. George Lasezkay to its Board as an Independent Director. Both have exceptional track records in the biotechnology industry and bring a wealth of ophthalmology experience to Amakem.Dr. Pakola was previou ... more
The Carl Zeiss AG Supervisory Board has elected Dr. Dieter Kurz as the new Chairman of the Supervisory Board, effective immediately. Born in 1948, Dr. Dieter Kurz studied physics at the University of Tübingen, from which he also received his doctorate. He joined Carl Zeiss in 1979. After ho ... more
“Merck delivered a reasonable operating performance in the face of a difficult year-over-year comparison,” said Karl-Ludwig Kley, Chairman of the Executive Board of Merck. “During the first quarter, we kicked off our efficiency program and announced the first planned initiatives as part of ... more
Intercell AG announced that it successfully completed a previously announced financing transaction consisting of a EUR 20.0 million secured loan (the “Term Loan”) provided by BB Biotech and an equity private placement (the “Private Placement”) of approximately EUR 15.2 million. The Intercel ... more
Intercell AG announced the signing of a combined debt and equity financing with BB Biotech. The investment through a fully owned subsidiary of BB Biotech AG consists of a EUR 20.0 million secured loan (the “Term Loan”) and a commitment to invest EUR 5.0 million as part of a proposed equity ... more
Avalanche Biotechnologies, Inc. and Lonza announced a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene therapy. AAV vectors are rapidly becoming one of the most promising gene delivery vehi ... more
Sygnature Discovery Limited and Pneumolabs (UK) Limited announced they have entered into a strategic alliance. Under the terms of the agreement, Sygnature and Pneumolabs will collaborate to provide a fully-integrated drug discovery service to accelerate clients’ drug discovery programmes i ... more
4-Antibody AG and Evotec AG announced the signing of a strategic collaboration agreement under which Evotec will offer a fully integrated antibody discovery and development service. Evotec’s novel and unique high throughput and high content screening approach coupled with 4-Antibody’s high ... more
Lab21 Limited has secured new patents in Europe and the USA relating to Hepatitis C (HCV) drug resistance as it continues to expand its intellectual property portfolio in infectious disease testing. The patents cover technology allowing the genotypic identification of drug resistant mutat ... more
Agenix Limited announced that Japan's Patent Office had granted a key patent covering the manufacturing process of its ThromboView® imaging agent for the detection of blood clots in humans. Agenix Chairman and Chief Executive Officer, Nicholas Weston said, "The granting of patent protectio ... more
BRAIN AG announced the granting of a European patent in the field of biotechnological wound conditioning. This new substance patent, registered under the official number EP2245150 B1, was invented by BRAIN within the scope of a BMBF supported research program (FKZ: 0313916). The patent desc ... more
Beckman Coulter, Inc. has obtained a CLIA Certificate of Registration, along with Massachusetts State Licensure, allowing Beckman Coulter Genomics to begin accepting clinical samples for genetic sequencing – the most technically complex CLIA category – and to provide those results to physic ... more
Offering a new and unique technology to propagate primary human cells to virtually unlimited numbers, Medicyte has now gone a step further in its high quality policy. As announced, its quality management system was certified in December 2011 to meet the criteria of the globally recognized s ... more
Cardio3 BioSciences (C3BS) announced that it has been granted Good Manufacturing Practice (GMP) Certification for its new production facilities in Mont-Saint-Guibert. Certification was granted by the Federal Agency for Medicines and Health Products (FAMHP), the authority responsible for the ... more
Drugs under development to treat those affected by acute spinal cord injuries are not expected to emerge within the current decade, leaving the market largely open to new entrants, according to a new report issued by pharmaceuticals intelligence provider GlobalData.The new report, "Acute Sp ... more
Clearbridge BioMedics has won the 2012 Asian Entrepreneurship Awards, which was held from 9-11 May 2012 in Kashiwanoha, Chiba Prefecture in Japan. A total of 18 start-up companies, from 12 Asian countries presented their business plans at this inaugural business competition. Clearbridge B ... more
Rare and niche diseases are being increasingly spotlighted by pharmaceutical and biotechnology corporations in the hope of developing initial treatments or improving upon existing therapies for these conditions, according to a new report released by GlobalData.The new report, "Rare and Nich ... more
A new report that the United States government is the largest funder of global health research and development (R&D) in the world, investing $12.7 billion over the past 10 years in the creation of new vaccines, drugs, diagnostics, and other products for neglected diseases of the developing ... more
The world is thirsty because we are hungry,” notes the United Nations on World Water Day. The world’s population reached 7 billion in 2011, and it is predicted to rise to at least 9 billion by 2050. More people living on our planet will require a more efficient use of dwindling natural res ... more
The Commission’s new European Innovation Partnership (EIP) sets the focus on the Common Agricultural Policy’s Rural Development Pillar and on the bioeconomy for delivering productive and sustainable agriculture across Europe. “The world is set to change dramatically over the coming decades” ... more
The pharma and biotech industries are increasingly seeking safer and more efficient supply chain processes. To meet these challenges Vetter has invested in a new, state-of-the-art Center for Visual Inspection and Logistics. The new facility offers high-bay warehousing capacity for cool and ... more
Genzyme, a Sanofi company, announced that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved a second suite for filling and finishing product at its Waterford, Ireland manufacturing plant. With this approval, Genzyme has nearly doubled its ability ... more
BASF will transfer the pharmaceutical production of KolliphorTM TPGS (Speziol®TPGS Pharma, vitamin E polyethylene glycol succinate), manufactured at the company’s Kankakee, Illinois (USA), site, to its Minden, Germany, facility. The transition is expected to be completed by the first quarte ... more
Eppendorf and the world-renowned journal Science are now accepting applications for the 2012 Eppendorf & Science Prize for Neurobiology. The Eppendorf & Science Prize for Neurobiology is an annual international research prize of US$ 25,000. It is awarded to one young scientist for his or he ... more
Only 21 percent of surveyed medical students could identify five true and two false indications of when and when not to wash their hands in the clinical setting, according to a study published in the American Journal of Infection Control.Three researchers from the Institute for Medical Micr ... more
GATC Biotech continues to grow in 2012. The company will expand the laboratories at its headquarters in Constance and plans to establish a new site in Cologne, Germany.The premises in Constance will become the new European Genome and Diagnostics Center with GATC Biotech’s fleet of Next and ... more
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2012 CHEMIE.DE Information Service GmbH, All rights reserved
